132 related articles for article (PubMed ID: 27531744)
1. Homo- and Heterotypic Association Regulates Signaling by the SgK269/PEAK1 and SgK223 Pseudokinases.
Liu L; Phua YW; Lee RS; Ma X; Jenkins Y; Novy K; Humphrey ES; Chan H; Shearer R; Ong PC; Dai W; Saunders DN; Lucet IS; Daly RJ
J Biol Chem; 2016 Oct; 291(41):21571-21583. PubMed ID: 27531744
[TBL] [Abstract][Full Text] [Related]
2. The pseudokinases SgK269 and SgK223: A novel oncogenic alliance in human cancer.
O'Rourke RL; Daly RJ
Cell Adh Migr; 2018; 12(6):524-528. PubMed ID: 29105536
[TBL] [Abstract][Full Text] [Related]
3. The pseudokinase SgK223 promotes invasion of pancreatic ductal epithelial cells through JAK1/Stat3 signaling.
Tactacan CM; Phua YW; Liu L; Zhang L; Humphrey ES; Cowley M; Pinese M; Biankin AV; Daly RJ
Mol Cancer; 2015 Jul; 14():139. PubMed ID: 26215634
[TBL] [Abstract][Full Text] [Related]
4. Structure of SgK223 pseudokinase reveals novel mechanisms of homotypic and heterotypic association.
Patel O; Griffin MDW; Panjikar S; Dai W; Ma X; Chan H; Zheng C; Kropp A; Murphy JM; Daly RJ; Lucet IS
Nat Commun; 2017 Oct; 8(1):1157. PubMed ID: 29079850
[TBL] [Abstract][Full Text] [Related]
5. The PEAK family of pseudokinases, their role in cell signalling and cancer.
Patel O; Roy MJ; Murphy JM; Lucet IS
FEBS J; 2020 Oct; 287(19):4183-4197. PubMed ID: 31599110
[TBL] [Abstract][Full Text] [Related]
6. The crystal structure of pseudokinase PEAK1 (Sugen kinase 269) reveals an unusual catalytic cleft and a novel mode of kinase fold dimerization.
Ha BH; Boggon TJ
J Biol Chem; 2018 Feb; 293(5):1642-1650. PubMed ID: 29212708
[TBL] [Abstract][Full Text] [Related]
7. Involvement of Lyn and the atypical kinase SgK269/PEAK1 in a basal breast cancer signaling pathway.
Croucher DR; Hochgräfe F; Zhang L; Liu L; Lyons RJ; Rickwood D; Tactacan CM; Browne BC; Ali N; Chan H; Shearer R; Gallego-Ortega D; Saunders DN; Swarbrick A; Daly RJ
Cancer Res; 2013 Mar; 73(6):1969-80. PubMed ID: 23378338
[TBL] [Abstract][Full Text] [Related]
8. PEAK3/C19orf35 pseudokinase, a new NFK3 kinase family member, inhibits CrkII through dimerization.
Lopez ML; Lo M; Kung JE; Dudkiewicz M; Jang GM; Von Dollen J; Johnson JR; Krogan NJ; Pawłowski K; Jura N
Proc Natl Acad Sci U S A; 2019 Jul; 116(31):15495-15504. PubMed ID: 31311869
[TBL] [Abstract][Full Text] [Related]
9. Distinct PEAK3 interactors and outputs expand the signaling potential of the PEAK pseudokinase family.
Hou J; Nguyen EV; Surudoi M; Roy MJ; Patel O; Lucet IS; Ma X; Daly RJ
Sci Signal; 2022 Feb; 15(722):eabj3554. PubMed ID: 35192416
[TBL] [Abstract][Full Text] [Related]
10. The inhibition of Panc1 cancer cells invasion by hAMSCs secretome through suppression of tyrosine phosphorylation of SGK223 (at Y411 site), c-Src (at Y416, Y530 sites), AKT activity, and JAK1/Stat3 signaling.
Safari F; Shafiee Nejad N; Aghaei Nejad A
Med Oncol; 2022 Jan; 39(3):28. PubMed ID: 35059869
[TBL] [Abstract][Full Text] [Related]
11. The PEAK1-PPP1R12B axis inhibits tumor growth and metastasis by regulating Grb2/PI3K/Akt signalling in colorectal cancer.
Ding C; Tang W; Wu H; Fan X; Luo J; Feng J; Wen K; Wu G
Cancer Lett; 2019 Feb; 442():383-395. PubMed ID: 30472186
[TBL] [Abstract][Full Text] [Related]
12. A novel SHP-1/Grb2-dependent mechanism of negative regulation of cytokine-receptor signaling: contribution of SHP-1 C-terminal tyrosines in cytokine signaling.
Minoo P; Zadeh MM; Rottapel R; Lebrun JJ; Ali S
Blood; 2004 Feb; 103(4):1398-407. PubMed ID: 14551136
[TBL] [Abstract][Full Text] [Related]
13. Signaling adaptor ShcD suppresses extracellular signal-regulated kinase (Erk) phosphorylation distal to the Ret and Trk neurotrophic receptors.
Wills MK; Keyvani Chahi A; Lau HR; Tilak M; Guild BD; New LA; Lu P; Jacquet K; Meakin SO; Bisson N; Jones N
J Biol Chem; 2017 Apr; 292(14):5748-5759. PubMed ID: 28213521
[TBL] [Abstract][Full Text] [Related]
14. The tyrosine phosphatase Shp2 interacts with NPM-ALK and regulates anaplastic lymphoma cell growth and migration.
Voena C; Conte C; Ambrogio C; Boeri Erba E; Boccalatte F; Mohammed S; Jensen ON; Palestro G; Inghirami G; Chiarle R
Cancer Res; 2007 May; 67(9):4278-86. PubMed ID: 17483340
[TBL] [Abstract][Full Text] [Related]
15. Dimerization of the Pragmin Pseudo-Kinase Regulates Protein Tyrosine Phosphorylation.
Lecointre C; Simon V; Kerneur C; Allemand F; Fournet A; Montarras I; Pons JL; Gelin M; Brignatz C; Urbach S; Labesse G; Roche S
Structure; 2018 Apr; 26(4):545-554.e4. PubMed ID: 29503074
[TBL] [Abstract][Full Text] [Related]
16. CCAAT/Enhancer binding protein delta (c/EBPdelta) regulation and expression in human mammary epithelial cells: II. Analysis of activating signal transduction pathways, transcriptional, post-transcriptional, and post-translational control.
Sivko GS; Sanford DC; Dearth LD; Tang D; DeWille JW
J Cell Biochem; 2004 Nov; 93(4):844-56. PubMed ID: 15389878
[TBL] [Abstract][Full Text] [Related]
17. SHEDding light on the role of Pragmin pseudo-kinases in cancer.
Roche S; Lecointre C; Simon V; Labesse G
Am J Cancer Res; 2019; 9(2):449-454. PubMed ID: 30906642
[TBL] [Abstract][Full Text] [Related]
18. A Stat3-interacting protein (StIP1) regulates cytokine signal transduction.
Collum RG; Brutsaert S; Lee G; Schindler C
Proc Natl Acad Sci U S A; 2000 Aug; 97(18):10120-5. PubMed ID: 10954736
[TBL] [Abstract][Full Text] [Related]
19. Production and purification of the PEAK pseudokinases for structural and functional studies.
Patel O; Surudoi M; Dai W; Hardy JM; Roy MJ; Lucet IS
Methods Enzymol; 2022; 667():1-35. PubMed ID: 35525538
[TBL] [Abstract][Full Text] [Related]
20. Identification of a PEAK1/ZEB1 signaling axis during TGFβ/fibronectin-induced EMT in breast cancer.
Agajanian M; Runa F; Kelber JA
Biochem Biophys Res Commun; 2015 Sep; 465(3):606-12. PubMed ID: 26297948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
